News | News By Subject | News by Disease News By Date | Search News

Premature Ejaculation News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Ampio Pharmaceuticals, Inc. (AMPE)'s Unit Vyrix Files For $29 Million IPO To Develop Anti-Premature Ejaculation Drug     4/21/2014
Furiex Pharmaceuticals, Inc. (FURX) Says Johnson & Johnson (JNJ) Returns Sexual Dysfunction Drug Rights     5/15/2012
Ampio Pharmaceuticals, Inc. (AMPE) Submits Pre-IND Package on Zertane to FDA     4/9/2012
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Phase III Clinical Results of PSD502 for Premature Ejaculation; Statistically And Clinically Significant Increase In All Three Co-Primary Endpoints     11/7/2008
FDA Rejects PPD, Inc. (PPDI) And Johnson & Johnson (JNJ)'s Premature Ejaculation Drug     10/27/2005
Johnson & Johnson (JNJ) Sees 10 To 13 New Drugs Approved By 2007     5/27/2005
King Pharmaceuticals (KG) And Palatin Technologies (PTN) Announce Strategic Alliance To Jointly Develop And Commercialize PT-141 As An Innovative Treatment For Sexual Dysfunction     8/13/2004
Ligand Pharmaceuticals Inc. (LGND) Earns $1.0 Million Milestone Payment As TAP Pharmaceutical Products Inc. Declares A Second SARM Clinical Candidate; The First Clinical Candidate Selected, LGD122941, Continues Toward IND Filing     7/9/2004
NexMed (NEXM) Reports Positive Results For Early Ejaculation Product; No Drugs Currently Approved For Treating Early Ejaculation     3/22/2004

News from Around the Web
Pelvic Floor Exercises May Help Lifelong Premature Ejaculation, Sapienza University Study     4/15/2014
New Drug Spray May Help Premature Ejaculation, University of California, San Francisco (UCSF) Study     6/3/2010
Pivotal Study For Sciele Pharma, Inc. (SCRX)'s PSD502 -- The First Potential Treatment For Premature Ejaculation     11/19/2009
Premature Ejaculation May Be A Genetic Disorder, Finnish Researchers Say     5/28/2009
Plethora Solutions Ltd. Penis Spray for Premature Ejaculation, Royal Victoria Hospital Study     4/27/2009
Topical Anaesthetic Spray Delays Ejaculation By Five Times As Long Says New Study     1/24/2007
Drug Shown To Improve Common Male Sexual Problem     9/8/2006
EMLA Cream Effective For Premature Ejaculation     3/28/2006
New Drug Delays Male Orgasms     5/24/2005
Mayo Researchers Find Link Between Lower Urinary Tract Symptoms And Sexual Dysfunction In Older Men     6/8/2004
Premature Ejaculation Pill In Development     2/25/2004

Press Releases
Tyna International Release: Revolutionary Sex Aid Promises To Transform The Sex Lives Of Millions Of Men With Erectile Dysfunction     9/26/2016
Ixchelsis Ltd Announces Positive Clinical Proof Of Concept Results For IX-01 In Treating Premature Ejaculation     1/25/2016
Innovus Pharma Announces The Beginning Of Patient Enrollment In Its Post-Marketing Ejectdelay™ Clinical Study In The Middle East     5/15/2014
Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States     2/21/2014
Innovus Pharma Files Its Product License Application for Commercialization of EjectDelay™ for Premature Ejaculation in Canada     10/29/2013
Innovus Pharma Readies the Launch of EjectDelay™ for Premature Ejaculation With Nationwide Sampling Program to Urologists in the U.S. Through the American Urology Association     9/24/2013
Ampio Pharmaceuticals, Inc. (AMPE) Contracts With Syngene to Manufacture Zertane-ED™, its Recently Patented Combination Drug to Treat Both Premature Ejaculation (PE) and Erectile Dysfunction (ED)     7/2/2012
Apricus Biosciences (APRI) Announces Expansion of Patent Portfolio for Topical Cream to Treat Premature Ejaculation With Issuance of Japanese Patent     1/14/2011
Furiex Pharmaceuticals, Inc. (FURX) Announces Issuance of U.S. Patent for Dapoxetine Method of Treatment     7/6/2010
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Final Analysis of PSD502 for Premature Ejaculation; All Primary and Secondary Endpoints Met in Phase III Pivotal Trial     12/8/2008
Ortho-McNeil Pharmaceutical, Inc. Release: First Medication Developed To Treat Premature Ejaculation Demonstrates Improvement In Control, Satisfaction And Time     5/23/2005
NexMed (NEXM) To Present Product Pipeline Update At Partnering Summit     3/17/2004
Enhance Biotech Inc. Announces Successful Completion Of Phase IIa Trial In Premature Ejaculation     1/27/2004

//-->